| Document |
Document Title |
|
WO/2019/142539A1 |
A composition comprising a compound represented by formula (I) and a compound represented by formula (III); a curable composition; and a compound. R11 represents an unsubstituted alkyl group. R12, R13, R32, and R33 each independently rep...
|
|
WO/2019/129403A1 |
The present invention concerns the field of neurodegenerative diseases, and in particular relates to compounds, pharmaceutical compositions and their uses in the protection of neuronal cells from inflammation and from oxidative stress in...
|
|
WO/2019/124154A1 |
Provided are: a polymerizable liquid-crystal compound suitable for producing positive-C-plate retarder films which have excellent heat resistance and reverse wavelength dispersion characteristics; a polymerizable liquid-crystal compositi...
|
|
WO/2019/111853A1 |
The present invention addresses the problem of providing a method for producing a dicarboxylic acid monoester with excellent production efficiency, a method for producing a polymerizable liquid crystal compound, and a novel dicarboxylic ...
|
|
WO/2019/108033A1 |
The present specification provides a compound represented by chemical formula 1, and an organic light emitting element comprising the same.
|
|
WO/2019/087054A1 |
The present invention relates to novel pharmaceutical composition comprising DPP-4 inhibitor, Alpha-lipoic acid and Vitamin B12. The synergism of DPP-4 inhibitor, Alpha- lipoic acid and Vitamin B12 helps in the treatment of diabetes and ...
|
|
WO/2019/071353A1 |
A method of reducing glutamate efflux from skeletal muscle by inhibiting system Xc- activity is provided. The method is useful for the treatment of statin-induced myalgia. Pharmaceutical compositions useful to treat statin-induced myalgi...
|
|
WO/2019/061299A1 |
Provided is a one-step amination reaction for producing an aminomethyl substituted heterocycloalkane, notably (tetrahydrofuran-2, 5-diyl) dimethanamine.
|
|
WO/2019/065043A1 |
Provided are a compound production method capable of producing a benzothiol compound having little coloration, a composition, and a curable composition. The method is for producing a compound represented by formula (1) and comprises reac...
|
|
WO/2019/044863A1 |
The present invention provides a cured product which is obtained by curing a curable composition that contains a compound represented by general formula 1, and which has a birefringence ∆n (587 nm) satisfying 0.00 ≤ ∆n (587 nm) ≤...
|
|
WO/2019/017445A1 |
The present invention addresses the problem of providing: a polymerizable liquid crystal compound which is used in formation of an optically anisotropic membrane having excellent reverse wavelength dispersibility; a polymerizable liquid ...
|
|
WO/2019/017444A1 |
The present invention addresses the problem of providing: a polymerizable liquid crystal compound which is used in formation of an optically anisotropic membrane having excellent reverse wavelength dispersibility and excellent moist heat...
|
|
WO/2018/167677A1 |
An object of the present invention is to provide a dithiolane compound or a salt or an N-oxide thereof that controls diseases. The present invention provides a dithiolane compound represented by Formula (1) or a salt or an N-oxide thereo...
|
|
WO/2018/155498A1 |
The present invention addresses the problem of providing a polymerizable liquid crystal compound that exhibits superior solubility and is used to form an optically anisotropic film exhibiting superior durability, and a method of producin...
|
|
WO/2018/128800A1 |
The disclosure is directed to compounds of formula (I). Methods of using these compounds, particularly as antimicrobial agents, are also described
|
|
WO/2018/119526A1 |
The invention relates to a natural biostimulant composition for improving agricultural production, specifically to a biostimulant composition for plants which contains lipoic acid and which is unknown in the prior art, and to a method fo...
|
|
WO/2018/101207A1 |
The present invention addresses the problem of providing: a polymerizable liquid crystal composition that makes it possible to manufacture an optical film that has excellent light resistance; and an optically anisotropic membrane, an opt...
|
|
WO/2018/049127A1 |
This invention provides confounds of the formula (I): wherein Y1, Y2 Z, X1, X2, and W are defined in the specification. These compounds are useful in the treatment of tyrosine kinases, MAPK signaling pathway kinases and Ρ13K/ΑΚΤ/mTor...
|
|
WO/2018/041935A1 |
The present invention relates to photoinitiator compounds of the formula (1) wherein X is O, S or a direct bond; Y is O, S or CR9R10; R1, R2, R3, R4, R5, R6, R7 and R8 independently of each other are hydrogen, halogen, C1- C18alkyl, C5-C...
|
|
WO/2018/033493A1 |
The present invention relates to liquid aromatic thioethers, a process for the preparation of the liquid aromatic thioethers, an article comprising the liquid aromatic thioethers as well as the use of the liquid aromatic thioethers as a ...
|
|
WO/2018/024901A1 |
The present invention relates to the use of a thianthrene-containing polymer as a redox-active electrode material, for example in the form of an electrode slurry, for electrical charge stores, in particular secondary batteries. The inven...
|
|
WO/2018/020974A1 |
Provided are the following: a sulfonium salt which does not contain a toxic metal and which exhibits higher cationic polymerization performance and crosslinking performance than a tetrakis(pentafluorophenyl)borate salt; a heat- or photo-...
|
|
WO/2018/014408A1 |
Provided are a light-emitting material, a preparation method therefor and an organic light-emitting diode using said light-emitting material. The light-emitting material has a single structure, a definite molecular weight, a better solub...
|
|
WO/2018/012762A1 |
The present invention relates to a novel compound and an organic electroluminescent device comprising same. The compound, according to the present invention, can be used in an organic layer, preferably a light-emitting layer, of an organ...
|
|
WO/2017/202266A1 |
The present invention relates to a 2-amino-3-substituted mercaptopropionate derivative, a preparation method therefor and a use thereof. The 2-amino-3-substituted mercaptopropionate derivative according to the present invention has a str...
|
|
WO/2017/181004A1 |
The disclosure of a compound of Formula (I) or a pharmaceutically acceptable salt thereof (I) The variables W, R1, R2, R3, and R4 are defined in the disclosure. The disclosure provides a compound or salt of Formula (I) together with a ph...
|
|
WO/2017/098988A1 |
The present invention provides a polymerizable liquid crystal compound that is highly soluble in various kinds of solvent and that has reverse-wavelength dispersibility or low-wavelength dispersibility. The present invention also provide...
|
|
WO/2017/093558A1 |
The invention relates to the dyeing of keratin materials using anionic direct dyes containing a disulfide heterocyclic group. The invention relates to a dye composition comprising a fluorescent dye containing a disulfide heterocyclic gro...
|
|
WO/2017/085733A2 |
The disclosure herein provides a composition of compound of formula 1. The disclosure also provides a method of synthesizing the compound of formula 1 and its improved processes. The compound of formula 1 or its pharmaceutical acceptable...
|
|
WO/2017/078927A1 |
Novel compounds having a formula (I), embodiments of a method of making the same, and of a composition comprising them are disclosed herein. Also disclosed are embodiments of a method of treating or preventing a metabolic disorder in a s...
|
|
WO/2017/060914A2 |
Penicillamine and its derivatives, composition, methods of synthesizing and using the compound of formula 1 are disclosed. The compounds of formula 1 also comprises of salts, polymorphs, solvates and hydrates thereof. The compounds may b...
|
|
WO/2017/017669A1 |
The invention relates to Pro-drugs, comprising red-ox-sensitive cleavage sites. The compounds may be utilized in medical practice for targeting of si RNA, antisense oligonucleotides or protein-based therapeutics to the cytoplasmatic comp...
|
|
WO/2017/013420A1 |
Compounds exhibiting high hole mobility and/or high glass transition temperatures together with favourable HOMO, LUMO and triplet levels are provided which are 2-(4'-Diphenylamino)phenyl-8-(1'-thianthrenyl)- dibenzothiophene and 4-(1-Thi...
|
|
WO/2016/126662A1 |
A composition for treating or preventing disease, especially vascular disease, including a composition chosen from FORMULAS I-VIII, ligands thereof, analogs thereof, a pharmaceutically acceptable salt thereof, a solvate thereof, an ester...
|
|
WO/2016/126667A1 |
A dietary supplement for daily oral ingestion by adult human beings, said dietary supplement including a palladium-lipoic acid compound. In some embodiments, the dietary supplement also includes glucosamine sulfate. In some embodiments, ...
|
|
WO/2016/115434A1 |
Provided herein are compounds useful for improving mRNA splicing in a cell. Exemplary compounds provided herein are useful for improving mRNA splicing in genes comprising at least one exon ending in the nucleotide sequence CAA. Methods f...
|
|
WO/2016/111310A1 |
The present invention addresses the problem of providing a novel compound having an angiotensin converting enzyme (ACE) inhibiting activity. The present invention relates to a compound represented by formula (I-1), a salt of the compound...
|
|
WO/2016/104317A1 |
The present invention addresses the problems of providing a polymerizable compound which, when added to a polymerizable composition, has high storage stability without causing any crystal precipitation, etc. and of providing a polymeriza...
|
|
WO/2016/073529A1 |
Provided are compositions, comprising a neolignan, ectoin, and a molecule of Formula I: wherein R1, R2 and R3 are independently H, methyl, ethyl, propyl, or isopropyl; wherein X is S or O. In some cases, the molecule of Formula I is ergo...
|
|
WO/2016/046292A1 |
The present invention relates to a liquid thioether carboxylic acid ester, a process for the preparation of the liquid thioether carboxylic acid ester, an article comprising the liquid thioether carboxylic acid ester as well as a use of ...
|
|
WO/2016/034963A1 |
Compounds of the formula (I) (I), wherein X is O, S, a direct bond or CR16R17; Y is O or S; R1, R2, R3, R4, R5, R6, R7 and R8 for example are hydrogen, halogen, C1-C4alkyl, or a group of formula (II) or (III) (II) (III) provided that eit...
|
|
WO/2015/158603A1 |
The invention relates to a compound of formula (I) or a salt thereof, where the symbols and indices are defined in the specification. The compounds of formula (I)are useful for combating animal pests and for combating parasites in and on...
|
|
WO/2015/138969A1 |
Novel compounds having a formula embodiments of a method of making the same, and of a composition comprising them are disclosed herein. Also disclosed are embodiments of a method of treating or preventing a metabolic disorder in a subjec...
|
|
WO/2015/128697A1 |
The present invention relates to molecules of formula (I) where R1 = -SO3H, -PO3H, -PO2(OH)2, -OPO2H2, -NHSO3H, -S (N=H)Me, SH, SR o guanidyl; R = C1-4 alkyl, phenyl or 5 or 6 membered aromatic nitrogen heterocycles; n = 1, 2, 3, 4 o 5; ...
|
|
WO/2015/118554A1 |
The disclosure herein provides 1-carbamoyloxyethyl 5-(1,2-dithiolan-3-yl)pentanoate derivatives of formula I, formula II and formula III. The disclosure also provides a method of synthesizing the compound of formula I, formula II and for...
|
|
WO/2015/095968A1 |
Described are covalent conjugates between lipoic acid (LA), or a derivative thereof, and resveratrol, or a derivative thereof. As an example, the covalent conjugate may be a compound of the formula: (I). Methods using the LA-resveratrol ...
|
|
WO/2015/080218A1 |
The purpose of the present invention is to provide: a polymerizable compound suitable as the material of an optically anisotropic body with excellent optical characteristics; a composition containing said polymerizable compound; a polyme...
|
|
WO/2015/044108A1 |
The invention relates to derivatives of 1,3-dithianes, 1,3-dithiolanes of the general formula (1a), and to salts thereof of the general formula (1b), where P = a polymer carrier, m = 1 or 2, Z is an organic linker or X = an inorganic or ...
|
|
WO/2015/039592A1 |
The present invention relates to the compound of formula (I), derivatives thereof, compositions comprising same, and the use thereof in the preparation of pharmaceuticals for the treatment and prevention of diseases benefitting from the ...
|
|
WO/2014/208284A1 |
The objective of the present invention is to provide: a composition for forming a thermoelectric conversion layer, the composition having exceptional thermoelectric properties; a thermoelectric conversion element in which said compositio...
|
